ENTG

Business Context and Reporting Period

Company: Entegris, Inc.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended July 1, 2006.
Business Overview: Entegris provides materials integrity management products and services for technology-driven industries, primarily semiconductors. The company completed a strategic merger with Mykrolis Corporation in August 2005, significantly expanding its product portfolio to include liquid and gas filters and delivery systems. The company changed its fiscal year-end to December 31, effective December 13, 2005.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 104% for the quarter and 94% for the six-month period compared to the prior year. This growth is primarily driven by the inclusion of Mykrolis operations (approx. $81M for the quarter and $153M for six months).
• Margin Expansion: Gross margins improved to 48.2% (Q2) and 47.3% (YTD) from 40.1% and 41.2% in the prior year, respectively, due to the higher-margin Mykrolis product mix and improved manufacturing utilization.
• Expense Increases: Selling, General, and Administrative (SG&A) expenses rose 119% (quarter) and 118% (YTD) due to Mykrolis infrastructure costs, integration expenses, and increased amortization of intangibles. Engineering, Research, and Development (ER&D) expenses increased 107% (quarter) and 130% (YTD) reflecting Mykrolis inclusion.
• Discontinued Operations: The company divested gas delivery, life science, and tape and reel product lines. These are reported as discontinued operations. The gas delivery assets were sold in February 2006 for net proceeds of $13.1 million.

Outlook, Risks, and Management Commentary

• Integration Status: Management expects to incur total integration expenses of up to $35 million related to the Mykrolis merger. Approximately $32 million has been recorded through July 1, 2006. The company believes cost synergies of approximately $20 million annually are largely in place.
• Capital Expenditures: Total capital expenditures for calendar 2006 are expected to be approximately $35 million.
• Liquidity: The company maintains a strong liquidity position with $311.3 million in cash and short-term investments. It has a $10 million unsecured revolving credit facility with no borrowings outstanding.
• Restructuring: The company announced the closure of its Bad Rappenau, Germany manufacturing plant, with estimated charges of $6.6 million for severance and asset impairment. $4.3 million of these costs were recognized in the first six months of 2006.
• Legal Proceedings: Entegris is involved in patent litigation with Pall Corporation (both as plaintiff and defendant) and settled a patent dispute with Miraial Co. Ltd. in June 2006.
• Internal Controls: A material weakness in internal control over financial reporting regarding purchase accounting for compensation matters was identified in 2005. Remediation efforts were completed, but the weakness is not considered fully remediated until the new controls are tested over a significant period.

Investor Verification Checklist

• Merger Synergies: Verify the realization of the projected $20 million in annualized cost savings from the Mykrolis integration.
• Inventory Levels: Monitor inventory growth ($29 million increase YTD) to ensure it aligns with sales demand and does not signal obsolescence risks.
• Foreign Currency Impact: Assess the sensitivity of future earnings to fluctuations in the Japanese yen and other international currencies, which negatively impacted sales by $6.2 million YTD.
• Legal Exposure: Track the status of ongoing patent litigation with Pall Corporation, including potential injunctions or profit disgorgement.
• Restructuring Costs: Confirm the remaining timeline and costs associated with the Bad Rappenau plant closure and relocation.